How Will The Colorectal Cancer Molecular Diagnostics Market Expand At A CAGR Of 8.3% Through 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Big Is The Colorectal Cancer Molecular Diagnostics Market Today And What Is Its Future Size?
In recent times, there has been significant growth in the size of the colorectal cancer molecular diagnostics market. It is projected to rise from $2.56 billion in 2024 to $2.76 billion in 2025, with a compound annual growth rate (CAGR) of 7.9%. This expansion during the historic period is the result of an escalating prevalence of colorectal cancer, heightened awareness and screening initiatives, increased focus on personalized medicine, and government strategies for cancer control.
The market size for colorectal cancer molecular diagnostics is predicted to experience substantial growth in the upcoming years. The market is projected to increase to $3.79 billion by 2029, with a compound annual growth rate of 8.3%. The anticipated growth during this forecast period can be associated with factors such as the aging of the population and increased prevalence of risk factors, integration of genetic data into clinical care, advancements in precision medicine, worldwide collaboration in cancer research. Foreseen major trends within this period encompass the increased focus on early detection biomarkers, the inclusion of artificial intelligence for data analysis, the emerging focus on circulating tumor DNA (CTDNA) evaluation, expansion of coordinated diagnostics for specialized therapies, and the concentration on immunotherapy biomarkers.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13120&type=smp
What External And Internal Drivers Are Influencing The Colorectal Cancer Molecular Diagnostics Market?
The rise in cases of inflammatory bowel diseases (IBD) is likely to drive the expansion of the colorectal cancer molecular diagnostic market in the future. IBD is a chronic gastrointestinal disorder characterized by inflammation of the digestive tract, primarily the colon and rectum. Symptoms include abdominal pain, diarrhea, and weight loss, which can be managed through medication, lifestyle alterations, and in some cases, surgery. The escalated occurrence of inflammatory bowel diseases underscores the need for precise, efficient, and advanced diagnostic solutions, which are crucial in determining the systemic therapy for colorectal cancer (CRC). This is because the diagnosis of CRC largely depends on the molecular evaluation of the tumor. For example, research by Crohn’s & Colitis UK in 2022 revealed that an estimated 500,000 people in the UK are living with Inflammatory Bowel Disease (IBD), a figure that is nearly twice the previous estimates. This was subsequently acknowledged by the UK Parliament in April 2024. Hence, the rising occurrences of inflammatory bowel diseases (IBD) will foster the growth of the colorectal cancer molecular diagnostic market.
How Is The Colorectal Cancer Molecular Diagnostics Market Categorized Across Applications And Types?
The colorectal cancer molecular diagnosticsmarket covered in this report is segmented –
1) By Type: Instruments; Reagents And Kits; Services
2) By Technology: Polymerase Chain Reaction (PCR); Sequencing; Mass Spectrometry; Transcription Mediated Amplification; Chips And Microarrays; Isothermal Nucleic Acid Amplification Technology (INAAT)
3) By End Users: Hospitals; Ambulatory Surgical Centers; Diagnostic Laboratories; Homecare Settings
Subsegments:
1) By Instruments: PCR Machines; Sequencers; Microarrays
2) By Reagents And Kits: DNA Or RNA Extraction Kits; Assay Kits; Reagent Packs
3) By Services: Diagnostic Testing Services; Genetic Testing Services; Consultation Services
Which Emerging Trends Are Reshaping The Colorectal Cancer Molecular Diagnostics Market Landscape?
Leading firms in the colorectal cancer molecular diagnostic market are centered on creating innovative molecular diagnostics and tailored medicine solutions, such as the Shield Blood Test method for detecting colorectal cancer at a more manageable and earlier stage. The Shield Blood Test is an initial screening procedure designed to identify early-stage colorectal cancer. For example, US-based biotech firm Guardant Health, known for its oncology molecular diagnostic products, launched its Shield Blood Test in May 2022. The Shield Test, which involves a simple blood draw, offers an accessible screening alternative that directly addresses the issue of patient compliance with screening. The test has shown a sensitivity of 91% in identifying colorectal cancer and 20% for identifying advanced adenomas, with a specificity rate of 92%. The Shield test leverages data from a varied range of cohorts totaling over 2,000 subjects with colorectal cancer, 357 with advanced adenoma, and 3,757 normal subjects to detect early signs of colorectal cancer in the blood.
Who Are The Global Leaders Steering The Colorectal Cancer Molecular Diagnostics Market Forward?
Major companies operating in the colorectal cancer molecular diagnostics market report are Johnson & Johnson, Bayer AG, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc., Guardant Health, Luminex Corporation, GenMark Diagnostics, Amoy Diagnostics Co. Ltd., MDxHealth Inc., HTG Molecular Diagnostics Inc., GenPath Diagnostics, geneOmbio Technologies Pvt.
Access The Complete Report Here:
What Are The Emerging Regional Trends Driving The Colorectal Cancer Molecular Diagnostics Market?
North America was the largest region in the colorectal cancer molecular diagnostics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13120&type=smp
Browse Through More Reports Similar to the Global Colorectal Cancer Molecular Diagnostics Market 2025, By The Business Research Company
Small Cell Lung Cancer Therapeutics Global Market Report 2025
Urinary Tract Cancer Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/urinary-tract-cancer-global-market-report
Blockchain Services Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/blockchain-services-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
